Pictet Asset Management (UK)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $38.5M | Buy |
491,372
+2,873
| +0.6% | +$225K | 0.04% | 394 |
|
|
2021
Q1 | $27.9M | Sell |
488,499
-150,961
| -24% | -$8.62M | 0.03% | 437 |
|
|
2020
Q4 | $53.6M | Sell |
639,460
-677,063
| -51% | -$56.7M | 0.07% | 299 |
|
|
2020
Q3 | $47.2M | Buy |
1,316,523
+343,456
| +35% | +$12.3M | 0.07% | 278 |
|
|
2020
Q2 | $23.5M | Buy |
973,067
+195,867
| +25% | +$4.74M | 0.04% | 374 |
|
|
2020
Q1 | $13.6M | Buy |
777,200
+55,463
| +8% | +$971K | 0.03% | 428 |
|
|
2019
Q4 | $12.6M | Sell |
721,737
-45,620
| -6% | -$795K | 0.02% | 514 |
|
|
2019
Q3 | $11.8M | Buy |
767,357
+28,009
| +4% | +$429K | 0.02% | 485 |
|
|
2019
Q2 | $15.3M | Buy |
+739,348
| New | +$15.3M | 0.03% | 436 |
|